Australia's Cochlear set for weekly drop; UBS hikes PT on FX adjustments

Cochlear

07/02/2025 02:59

** Shares of Cochlear  COH.AX  fall as much as 1.3% to
A$309.090
    ** Shares of the healthcare technology co set for their
weakest week since December 9, 2024, if losses hold 
    ** The priciest stock in ASX is tracking losses seen by the
country's healthcare sub-index  .AXHJ , which is down 0.7%
    ** UBS hikes stock's price target to A$270 from A$265,
retains "sell" rating
    ** Brokerage made changes to their foreign exchange
estimates, underlying assumptions are unchanged
    ** Three of 15 analysts rate the stock "buy" or higher, 10
"hold" and two "sell"; their median PT is A$305.00 – LSEG data
    ** Stock fell 8.8% in 2024
    

 (Reporting by Nichiket Sunil in Bengaluru)
 ((Nichiket.Sunil@thomsonreuters.com;))